KMS Medisurgi Ltd
BSE:540468
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
KMS Medisurgi Ltd
BSE:540468
|
IN |
|
B
|
Benefitfocus Inc
F:BTF
|
US |
|
E
|
Etablissementen Franz Colruyt NV
LSE:0N4Y
|
BE |
|
B+S Banksysteme AG
XETRA:DTD2
|
DE |
|
H
|
Huazhu Group Ltd
NASDAQ:HTHT
|
CN |
Cash Flow Statement
Cash Flow Statement
KMS Medisurgi Ltd
| Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
2
|
2
|
2
|
3
|
7
|
13
|
6
|
(1)
|
6
|
|
| Depreciation & Amortization |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
(0)
|
0
|
(0)
|
1
|
2
|
3
|
3
|
2
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Change in Working Capital |
0
|
(6)
|
(6)
|
2
|
(5)
|
(5)
|
3
|
3
|
(2)
|
|
| Cash from Operating Activities |
5
N/A
|
(0)
N/A
|
(1)
-260%
|
7
N/A
|
5
-34%
|
11
+133%
|
12
+13%
|
5
-58%
|
7
+47%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(1)
|
(7)
|
(7)
|
(1)
|
(1)
|
(2)
|
(3)
|
|
| Other Items |
1
|
1
|
0
|
0
|
(0)
|
0
|
(4)
|
(11)
|
(7)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-17%
|
(1)
+14%
|
(7)
-577%
|
(7)
+7%
|
(1)
+90%
|
(5)
-656%
|
(13)
-153%
|
(10)
+27%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Debt |
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(9)
|
(5)
|
8
|
4
|
|
| Cash Paid for Dividends |
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Cash from Financing Activities |
(1)
N/A
|
(1)
+34%
|
(0)
+48%
|
(0)
+79%
|
(0)
-10%
|
(9)
-11 288%
|
(5)
+51%
|
8
N/A
|
3
-65%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
3
N/A
|
(2)
N/A
|
(2)
+4%
|
(0)
+87%
|
(2)
-741%
|
1
N/A
|
2
+336%
|
(0)
N/A
|
0
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
4
N/A
|
(2)
N/A
|
(2)
+14%
|
(0)
+81%
|
(2)
-508%
|
10
N/A
|
11
+9%
|
3
-74%
|
4
+54%
|
|